Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.85). Revenue for the quarter came in at $460 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• S&P 500 may pull back before midterms, but Citi says buy the dip
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance